Akebia Therapeutics, Inc. (AKBA)

$ 2.95
   
  • Change Today:
    $-0.04
  • 52 Week High: $4.01
  • 52 Week Low: $1.28
  • Currency: US Dollars
  • Shares Issued: 117.12m
  • Volume: 2,253,961
  • Market Cap: $345.51m
  • RiskGrade: 517

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 226.00 31.93 (2.20)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 298.52 61.04 10.00¢ 29.5 n/a n/a n/a 0.0%
31-Dec-27 314.79 56.36 10.25¢ 28.8 11.5 +2% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

AKBA Market Data

Currency US Dollars
Share Price $ 2.95
Change Today $ -0.04
% Change -1.34 %
52 Week High $4.01
52 Week Low $1.28
Volume 2,253,961
Shares Issued 117.12m
Market Cap $345.51m
RiskGrade 517

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 12-Sep-2025

Time Volume / Share Price
16:00 301,273 @ $2.95
15:59 100 @ $2.95
15:59 100 @ $2.95
15:59 100 @ $2.95
15:59 157 @ $2.95

Top of Page